Clinical Trial

TENS During Transperineal Prostate Biopsy

Study acronym: TENS 2
Recruiting
View on ClinicalTrials.gov →
Summary
Transperineal prostate biopsy is a safe and effective method of diagnosing prostate cancer. When performed under local anaesthesia in an outpatient setting, it can cause significant pain, particularly during the periprostatic nerve block - the injection of local anaesthetic around the prostate. Better pain management during this procedure may improve patient comfort and encourage wider use of the transperineal approach. Transcutaneous electrical nerve stimulation (TENS) is a non-invasive, low-cost method of pain relief that works by delivering mild electrical impulses through the skin. A preceding pilot study at our centre (n=84) found that TENS used alongside local anaesthesia was associated with significantly lower pain scores during periprostatic nerve block and biopsy sampling, with no device-related complications. This study aims to confirm these findings in a larger, formally powered, triple-blind, randomized controlled trial. Participants will be randomly assigned to receive either active TENS or sham TENS (electrodes applied but no electrical current delivered) in addition to standard local anaesthesia. Neither the participant nor the operating urologist will know which group the participant is in. Pain scores are written down by the participant himself, so nobody asks him for a number during the procedure. Stimulation may feel strong, weak or not noticeable at all, and feeling nothing does not mean a participant is in the inactive group. Pain intensity will be assessed at four stages of the procedure using a 0-10 numeric rating scale. Participants will be followed up at 30 days after the biopsy.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-08-14
notable Primary completion pushed: 2027-01 -> 2027-04 2026-08-05
minor Completion pushed: 2027-02 -> 2027-05 2026-08-05
Trial Details
NCT Number NCT07578324
Lead Sponsor Medical University of Gdansk
Conditions Prostate Cancer (Diagnosis), Prostate Biopsy, Pain, Procedural
Enrollment 140 participants
Start Date 2026-08-12
Primary Completion 2027-04 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-08-13